<?xml version="1.0"?>
<rss version="2.0">
   <channel>
   <title>NAPSer vesti</title>
   <link>http://www.napser.org/newsletter/mail.cgi/list/napservesti/</link>
   <description>Najnovije informacije iz sveta farmacije u vašem elektronskom sandučetu.</description>
   <language>en-us</language>
   <lastBuildDate>Mon, 06 Feb 2012 19:17:00 GMT</lastBuildDate>
   <generator>Dada Mail 4.3.0 Stable 11/26/10</generator>
   
    
	 
		<item>
		 <title>NAPSer vesti Message</title>
		 <link>http://www.napser.org/newsletter/mail.cgi/archive/napservesti/20110327110239/</link>
		 <description>



&#60;P style=&#34;MARGIN: 0in 0in 10pt&#34; class=MsoNormal&#62;&#60;?xml:namespace prefix = o ns = 
&#34;urn:schemas-microsoft-com:office:office&#34; /&#62;&#60;o:p&#62;&#60;FONT 
face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/o:p&#62;&#60;/P&#62;
&#60;TABLE 
style=&#34;BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-COLLAPSE: collapse; BORDER-TOP: medium none; BORDER-RIGHT: medium none; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt; mso-border-insideh: none; mso-border-insidev: none&#34; 
class=MsoTableGrid border=0 cellSpacing=0 cellPadding=0&#62;
  
  &#60;TR style=&#34;mso-yfti-irow: 0; mso-yfti-firstrow: yes&#34;&#62;
    &#60;TD 
    style=&#34;BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; WIDTH: 239.4pt; PADDING-RIGHT: 5.4pt; BACKGROUND: #00b050; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0in; mso-border-alt: solid windowtext .5pt&#34; 
    vAlign=top width=319&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; 
      class=MsoNormal&#62;&#60;U&#62;&#60;SPAN 
      style=&#34;COLOR: white; FONT-SIZE: 14pt; mso-themecolor: background1&#34;&#62;&#60;o:p&#62;&#60;SPAN 
      style=&#34;TEXT-DECORATION: none&#34;&#62;&#60;FONT 
      face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/SPAN&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/U&#62;&#60;/P&#62;
      &#60;P style=&#34;TEXT-ALIGN: center; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; 
      class=MsoNormal align=center&#62;&#60;B style=&#34;mso-bidi-font-weight: normal&#34;&#62;&#60;SPAN 
      style=&#34;COLOR: white; FONT-SIZE: 36pt; mso-themecolor: background1&#34;&#62;&#60;FONT 
      face=Calibri&#62;NAPSer Vesti&#60;o:p&#62;&#60;/o:p&#62;&#60;/FONT&#62;&#60;/SPAN&#62;&#60;/B&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; 
      class=MsoNormal&#62;&#60;U&#62;&#60;SPAN 
      style=&#34;COLOR: white; FONT-SIZE: 14pt; mso-themecolor: background1&#34;&#62;&#60;o:p&#62;&#60;SPAN 
      style=&#34;TEXT-DECORATION: none&#34;&#62;&#60;FONT 
      face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/SPAN&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/U&#62;&#60;/P&#62;&#60;/TD&#62;
    &#60;TD 
    style=&#34;BORDER-BOTTOM: #f0f0f0; BORDER-LEFT: #f0f0f0; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 239.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #f0f0f0; BORDER-RIGHT: #f0f0f0; PADDING-TOP: 0in; mso-border-left-alt: solid windowtext .5pt&#34; 
    vAlign=top width=319&#62;
      &#60;P style=&#34;TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; 
      class=MsoNormal align=right&#62;&#60;B style=&#34;mso-bidi-font-weight: normal&#34;&#62;&#60;SPAN 
      style=&#34;COLOR: #00b050; FONT-SIZE: 20pt&#34;&#62;&#60;FONT 
      face=Calibri&#62;Nedelja&#60;o:p&#62;&#60;/o:p&#62;&#60;/FONT&#62;&#60;/SPAN&#62;&#60;/B&#62;&#60;/P&#62;
      &#60;P style=&#34;TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; 
      class=MsoNormal align=right&#62;&#60;B style=&#34;mso-bidi-font-weight: normal&#34;&#62;&#60;SPAN 
      style=&#34;COLOR: #00b050; FONT-SIZE: 20pt&#34;&#62;&#60;FONT face=Calibri&#62;27. 
      Mart&#60;o:p&#62;&#60;/o:p&#62;&#60;/FONT&#62;&#60;/SPAN&#62;&#60;/B&#62;&#60;/P&#62;
      &#60;P style=&#34;TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; 
      class=MsoNormal align=right&#62;&#60;B style=&#34;mso-bidi-font-weight: normal&#34;&#62;&#60;SPAN 
      style=&#34;COLOR: #00b050; FONT-SIZE: 20pt&#34;&#62;&#60;FONT 
      face=Calibri&#62;2011&#60;/FONT&#62;&#60;/SPAN&#62;&#60;/B&#62;&#60;/P&#62;&#60;/TD&#62;&#60;/TR&#62;
  &#60;TR style=&#34;mso-yfti-irow: 1&#34;&#62;
    &#60;TD 
    style=&#34;BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #f0f0f0; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 239.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #f0f0f0; BORDER-RIGHT: #f0f0f0; PADDING-TOP: 0in; mso-border-top-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt&#34; 
    vAlign=top width=319&#62;
      &#60;P style=&#34;MARGIN: 0in 0in 3pt&#34;&#62;&#60;o:p&#62;&#38;nbsp;&#60;/o:p&#62;&#60;/P&#62;
      &#60;P style=&#34;MARGIN: 0in 0in 3pt&#34;&#62;&#60;SPAN style=&#34;FONT-SIZE: 18pt&#34;&#62;Dobro došli u 
      107. NAPSer Vesti!&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;MARGIN: 0in 0in 3pt&#34;&#62;&#60;o:p&#62;&#38;nbsp;&#60;/o:p&#62;&#60;/P&#62;
      &#60;P style=&#34;MARGIN: 0in 0in 3pt&#34;&#62;Najnovije vesti, informacije o dogadajima 
      kod nas i u svetu direktno u vašem elektronskom poštanskom sanducetu.&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 3pt&#34; 
      class=MsoNormal&#62;&#60;o:p&#62;&#60;FONT face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/o:p&#62;&#60;/P&#62;
      &#60;P style=&#34;MARGIN: 0in 0in 3pt&#34;&#62;&#60;A href=&#34;http://www.napser.org&#34; 
      target=_blank&#62;&#60;STRONG&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #00b050; FONT-SIZE: 14pt; TEXT-DECORATION: none; text-underline: none&#34;&#62;www.napser.org&#60;/SPAN&#62;&#60;/STRONG&#62;&#60;/A&#62;&#60;SPAN 
      style=&#34;COLOR: #00b050; FONT-SIZE: 14pt&#34;&#62;&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; 
      class=MsoNormal&#62;&#60;o:p&#62;&#60;FONT face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/o:p&#62;&#60;/P&#62;&#60;/TD&#62;
    &#60;TD 
    style=&#34;BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #f0f0f0; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 239.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #f0f0f0; BORDER-RIGHT: #f0f0f0; PADDING-TOP: 0in; mso-border-bottom-alt: solid windowtext .5pt&#34; 
    vAlign=top width=319&#62;
      &#60;P style=&#34;TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; 
      class=MsoNormal align=right&#62;&#60;o:p&#62;&#60;FONT 
    face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/o:p&#62;&#60;/P&#62;&#60;/TD&#62;&#60;/TR&#62;
  &#60;TR style=&#34;mso-yfti-irow: 2&#34;&#62;
    &#60;TD 
    style=&#34;BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; WIDTH: 6.65in; PADDING-RIGHT: 5.4pt; BACKGROUND: #00b050; BORDER-TOP: #f0f0f0; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0in; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt&#34; 
    vAlign=top width=638 colSpan=2&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;COLOR: black; mso-themecolor: text1&#34;&#62;&#60;o:p&#62;&#60;FONT 
      face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;&#60;/TD&#62;&#60;/TR&#62;
  &#60;TR style=&#34;mso-yfti-irow: 3&#34;&#62;
    &#60;TD 
    style=&#34;BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #f0f0f0; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 6.65in; PADDING-RIGHT: 5.4pt; BORDER-TOP: #f0f0f0; BORDER-RIGHT: #f0f0f0; PADDING-TOP: 0in; mso-border-top-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt&#34; 
    vAlign=top width=638 colSpan=2&#62;
      &#60;P style=&#34;TEXT-ALIGN: center; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; 
      class=MsoNormal align=center&#62;&#60;B style=&#34;mso-bidi-font-weight: normal&#34;&#62;&#60;SPAN 
      style=&#34;mso-ansi-language: SR&#34; lang=SR&#62;&#60;o:p&#62;&#60;FONT 
      face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/B&#62;&#60;/P&#62;
      &#60;P style=&#34;TEXT-ALIGN: center; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; 
      class=MsoNormal align=center&#62;&#60;B style=&#34;mso-bidi-font-weight: normal&#34;&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 14pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;PRIRUCNIK ZA STAŽERE&#60;SPAN style=&#34;mso-spacerun: yes&#34;&#62;&#38;nbsp; 
      &#60;/SPAN&#62;DIPLOMIRANE FARMACEUTE&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/B&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;COLOR: black; mso-themecolor: text1&#34;&#62;&#60;o:p&#62;&#60;FONT 
      face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;&#60;/TD&#62;&#60;/TR&#62;
  &#60;TR style=&#34;mso-yfti-irow: 4&#34;&#62;
    &#60;TD 
    style=&#34;BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; WIDTH: 6.65in; PADDING-RIGHT: 5.4pt; BACKGROUND: #00b050; BORDER-TOP: #f0f0f0; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0in; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt&#34; 
    vAlign=top width=638 colSpan=2&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;COLOR: black; mso-themecolor: text1&#34;&#62;&#60;o:p&#62;&#60;FONT 
      face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;&#60;/TD&#62;&#60;/TR&#62;
  &#60;TR style=&#34;mso-yfti-irow: 5&#34;&#62;
    &#60;TD 
    style=&#34;BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #f0f0f0; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 6.65in; PADDING-RIGHT: 5.4pt; BORDER-TOP: #f0f0f0; BORDER-RIGHT: #f0f0f0; PADDING-TOP: 0in; mso-border-top-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt&#34; 
    vAlign=top width=638 colSpan=2&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;mso-ansi-language: SR&#34; lang=SR&#62;&#60;o:p&#62;&#60;FONT 
      face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;Mr ph spec Marija Stijovic&#60;SPAN 
      style=&#34;mso-spacerun: yes&#34;&#62;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp; 
      &#60;/SPAN&#62;&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;Mr ph spec Nataša Nikolic&#60;SPAN 
      style=&#34;mso-spacerun: yes&#34;&#62;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp; 
      &#60;/SPAN&#62;&#60;U&#62;&#60;SPAN 
      style=&#34;mso-spacerun: yes&#34;&#62;&#38;nbsp;&#60;/SPAN&#62;&#60;o:p&#62;&#60;/o:p&#62;&#60;/U&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;o:p&#62;&#38;nbsp;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;I 
      style=&#34;mso-bidi-font-style: normal&#34;&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;Recenzent&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/I&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 12pt; mso-bidi-font-weight: bold; mso-ansi-language: SR&#34; 
      lang=SR&#62;Prof. dr sc. med. Bogdan Boškovic&#60;/SPAN&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;,&#60;BR&#62;Vojnomedicinska akademija, Klinika za urgentnu&#60;BR&#62;i klinicku 
      toksikologiju i farmakologiju&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; 
      class=MsoNormal&#62;&#60;U&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;o:p&#62;&#60;SPAN 
      style=&#34;TEXT-DECORATION: none&#34;&#62;&#38;nbsp;&#60;/SPAN&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/U&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;I 
      style=&#34;mso-bidi-font-style: normal&#34;&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;Izdavac&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/I&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;Farmaceutsko društvo Srbije&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;Beograd, 2010.&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;o:p&#62;&#38;nbsp;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;Autorke su u okviru ovog Prirucnika, prvog ove vrste u našoj 
      zemlji, na osnovu vlastitih iskustava i problema sa kojima su se sretale 
      tokom stažiranja u apoteci i u radu sa pacijentima, pokušale da doprinesu 
      rešenju najcešcih problema. Na osnovu svetski relevantnih i najnovijih 
      literaturnih podataka dat je opis zdravstvenih problema za koje se 
      pacijent najcešce obraca farmaceutu. Svako poglavlje namenjeno je kao 
      podrška farmaceutu pre, tokom i nakon izdavanja leka. Posebna pažnja je 
      posvecena prepoznavanju ozbiljnosti simpotoma i znakova uocenih 
      zdravstvenih problema, koji zahtevaju upucivanje pacijenta nadležnom 
      lekaru. &#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;o:p&#62;&#38;nbsp;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;Izmedu ostalog prirucnik sadrži:&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;o:p&#62;&#38;nbsp;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P 
      style=&#34;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-add-space: auto; mso-list: l0 level1 lfo1; mso-hyphenate: none&#34; 
      class=MsoListParagraphCxSpFirst&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: Symbol; FONT-SIZE: 12pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;SPAN style=&#34;mso-list: Ignore&#34;&#62;·&#60;SPAN 
      style=&#34;FONT: 7pt 'Times New Roman'&#34;&#62;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp; 
      &#60;/SPAN&#62;&#60;/SPAN&#62;&#60;/SPAN&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;definiciju oboljenja, najcešce uzroke nastanka, simptome i znake 
      na koje se pacijent žali, pitanja koja se postavljaju pacijentima, predlog 
      terapije, kao i podsetnik za farmaceute i savet za 
      pacijenta.&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P 
      style=&#34;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-add-space: auto; mso-list: l0 level1 lfo1; mso-hyphenate: none&#34; 
      class=MsoListParagraphCxSpMiddle&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: Symbol; FONT-SIZE: 12pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;SPAN style=&#34;mso-list: Ignore&#34;&#62;·&#60;SPAN 
      style=&#34;FONT: 7pt 'Times New Roman'&#34;&#62;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp; 
      &#60;/SPAN&#62;&#60;/SPAN&#62;&#60;/SPAN&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;kratki prikaz klinicki dokazanih svojstava dijetetskih suplemenata 
      i vitamina, kao i klinicki znacajnih interakcija sa 
      lekovima&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P 
      style=&#34;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-add-space: auto; mso-list: l0 level1 lfo1; mso-hyphenate: none&#34; 
      class=MsoListParagraphCxSpMiddle&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: Symbol; FONT-SIZE: 12pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;SPAN style=&#34;mso-list: Ignore&#34;&#62;·&#60;SPAN 
      style=&#34;FONT: 7pt 'Times New Roman'&#34;&#62;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp; 
      &#60;/SPAN&#62;&#60;/SPAN&#62;&#60;/SPAN&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;opšti saveti i uputstva za pravilno korišcenje razlicitih 
      farmaceutskih oblika sa spoljnu i unutrašnju upotrebu. 
      &#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P 
      style=&#34;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-add-space: auto; mso-list: l0 level1 lfo1; mso-hyphenate: none&#34; 
      class=MsoListParagraphCxSpMiddle&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: Symbol; FONT-SIZE: 12pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;SPAN style=&#34;mso-list: Ignore&#34;&#62;·&#60;SPAN 
      style=&#34;FONT: 7pt 'Times New Roman'&#34;&#62;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp; 
      &#60;/SPAN&#62;&#60;/SPAN&#62;&#60;/SPAN&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;racionalna primena antibiotika u primarnoj zdravstvenoj zaštiti u 
      svetu&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P 
      style=&#34;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-add-space: auto; mso-list: l0 level1 lfo1; mso-hyphenate: none&#34; 
      class=MsoListParagraphCxSpMiddle&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: Symbol; FONT-SIZE: 12pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;SPAN style=&#34;mso-list: Ignore&#34;&#62;·&#60;SPAN 
      style=&#34;FONT: 7pt 'Times New Roman'&#34;&#62;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp; 
      &#60;/SPAN&#62;&#60;/SPAN&#62;&#60;/SPAN&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;primena lekova u osetljivoj populaciji &#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P 
      style=&#34;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-add-space: auto; mso-list: l0 level1 lfo1; mso-hyphenate: none&#34; 
      class=MsoListParagraphCxSpMiddle&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: Symbol; FONT-SIZE: 12pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;SPAN style=&#34;mso-list: Ignore&#34;&#62;·&#60;SPAN 
      style=&#34;FONT: 7pt 'Times New Roman'&#34;&#62;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp; 
      &#60;/SPAN&#62;&#60;/SPAN&#62;&#60;/SPAN&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;neželjena dejstva lekova i interakcije 
lekova&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P 
      style=&#34;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-add-space: auto; mso-list: l0 level1 lfo1; mso-hyphenate: none&#34; 
      class=MsoListParagraphCxSpMiddle&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: Symbol; FONT-SIZE: 12pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;SPAN style=&#34;mso-list: Ignore&#34;&#62;·&#60;SPAN 
      style=&#34;FONT: 7pt 'Times New Roman'&#34;&#62;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp; 
      &#60;/SPAN&#62;&#60;/SPAN&#62;&#60;/SPAN&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;relevantne zdravstvene institucije i udruženja pacijenata 
      &#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P 
      style=&#34;LINE-HEIGHT: normal; TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in; mso-add-space: auto; mso-list: l0 level1 lfo1; mso-hyphenate: none&#34; 
      class=MsoListParagraphCxSpLast&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: Symbol; FONT-SIZE: 12pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;SPAN style=&#34;mso-list: Ignore&#34;&#62;·&#60;SPAN 
      style=&#34;FONT: 7pt 'Times New Roman'&#34;&#62;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp; 
      &#60;/SPAN&#62;&#60;/SPAN&#62;&#60;/SPAN&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;pored svakog nezašticenog naziva leka uneti su i odgovarajuci 
      komercijalni nazivi registrovanih lekova na tržištu Srbije. 
      &#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;o:p&#62;&#38;nbsp;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;Iako je prvenstveno namenjen stažerima farmaceutima, Prirucnik 
      može da bude od koristi za osvežavanje znanja i uporedivanje vlastitih 
      stavova i iskusnim farmaceutima i lekarima opšte 
      prakse.&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;o:p&#62;&#38;nbsp;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;Više informacija možete dobili na internet sajtu Farmaceutskog 
      društva Srbije, &#60;/SPAN&#62;&#60;A href=&#34;http://www.farmacija.org&#34;&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;FONT color=#0000ff&#62;www.farmacija.org&#60;/FONT&#62;&#60;/SPAN&#62;&#60;/A&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62; , gde možete naci i telefon kontakt. Autorkama možete direktno 
      pisati i na mail &#60;/SPAN&#62;&#60;A href=&#34;mailto:&#38;#117;&#38;#x64;&#38;#x72;&#38;#x69;&#38;#112;&#38;#111;&#38;#112;&#38;#x72;&#38;#105;&#38;#114;&#38;#x75;&#38;#99;&#38;#x6E;&#38;#105;&#38;#107;&#38;#117;&#38;#x40;&#38;#103;&#38;#109;&#38;#x61;&#38;#x69;&#38;#108;&#38;#46;&#38;#99;&#38;#x6F;&#38;#x6D;&#34;&#62;&#60;FONT 
      color=#0000ff&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;udripoprirucniku&#60;/SPAN&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: IT&#34; 
      lang=IT&#62;@gmail.com&#60;/SPAN&#62;&#60;/FONT&#62;&#60;/A&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: IT&#34; 
      lang=IT&#62;.&#60;/SPAN&#62;&#60;SPAN 
      style=&#34;FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 12pt; mso-ansi-language: SR&#34; 
      lang=SR&#62;&#60;SPAN 
      style=&#34;mso-spacerun: yes&#34;&#62;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp;&#38;nbsp; 
      &#60;/SPAN&#62;&#60;o:p&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;FONT-SIZE: 12pt; mso-ansi-language: SR&#34; lang=SR&#62;&#60;o:p&#62;&#60;FONT 
      face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;COLOR: black; mso-themecolor: text1&#34;&#62;&#60;o:p&#62;&#60;FONT 
      face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;&#60;/TD&#62;&#60;/TR&#62;
  &#60;TR style=&#34;mso-yfti-irow: 6; mso-yfti-lastrow: yes&#34;&#62;
    &#60;TD 
    style=&#34;BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0in; PADDING-LEFT: 5.4pt; WIDTH: 6.65in; PADDING-RIGHT: 5.4pt; BACKGROUND: #00b050; BORDER-TOP: #f0f0f0; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0in; mso-border-alt: solid windowtext .5pt; mso-border-top-alt: solid windowtext .5pt&#34; 
    vAlign=top width=638 colSpan=2&#62;
      &#60;P style=&#34;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt&#34; class=MsoNormal&#62;&#60;SPAN 
      style=&#34;COLOR: black; mso-themecolor: text1&#34;&#62;&#60;o:p&#62;&#60;FONT 
      face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/o:p&#62;&#60;/SPAN&#62;&#60;/P&#62;&#60;/TD&#62;&#60;/TR&#62;&#60;/TABLE&#62;
&#60;P style=&#34;MARGIN: 0in 0in 10pt&#34; class=MsoNormal&#62;&#60;o:p&#62;&#60;FONT 
face=Calibri&#62;&#38;nbsp;&#60;/FONT&#62;&#60;/o:p&#62;&#60;/P&#62;




&lt;!-- begin subscription_form_widget.tmpl --&gt; 



 

    &lt;form action=&quot;http://www.napser.org/newsletter/mail.cgi&quot; method=&quot;post&quot;&gt;

 

&lt;fieldset&gt;
&lt;legend&gt;
 Subscribe/Unsubscribe  on NAPSer vesti
&lt;/legend&gt;

 
    

    &lt;input type=&quot;hidden&quot; name=&quot;list&quot; value=&quot;napservesti&quot; /&gt;


&lt;p&gt;
&lt;label for=&quot;email&quot; style=&quot;width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block&quot; &gt;
Email&amp;nbsp;Address: 
&lt;/label&gt;
 
	&lt;input type=&quot;text&quot; name=&quot;email&quot; id=&quot;email&quot; value=&quot;&quot; /&gt; &lt;span class=&quot;error&quot;&gt;* Required&lt;/span&gt;
 

&lt;/p&gt;

 

	 

 


&lt;hr style=&quot;border-top: 1px solid black;&quot; /&gt; 

 
    &lt;p&gt;
    &lt;label for=&quot;f_s&quot; style=&quot;width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block&quot;&gt;
    Subscribe
    &lt;/label&gt;
    &lt;input type=&quot;radio&quot; name=&quot;f&quot; id=&quot;f_s&quot; value=&quot;subscribe&quot; checked=&quot;checked&quot; /&gt;
    &lt;/p&gt; 
    
    &lt;p&gt; 
    &lt;label for=&quot;f_u&quot; style=&quot;width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block&quot;&gt;Unsubscribe&lt;/label&gt; 
    &lt;input type=&quot;radio&quot; name=&quot;f&quot;  id=&quot;f_u&quot;  value=&quot;unsubscribe&quot;  /&gt;
    &lt;/p&gt;   

 

&lt;hr style=&quot;border-top: 1px solid black;&quot; /&gt; 

&lt;p style=&quot;text-align:right;display:block&quot;&gt;
&lt;input type=&quot;submit&quot; value=&quot;Submit Your Information&quot; class=&quot;processing&quot; /&gt;
&lt;/p&gt; 


 

    &lt;p style=&quot;font-size:10px;font-family:Verdana,Arial,sans-serif;&quot;&gt;&lt;a href=&quot;http://dadamailproject.com&quot; target=&quot;_blank&quot; style=&quot;font-size:10px;font-family:Verdana,Arial,sans-serif;&quot;&gt;Powered by Dada Mail 4.3.0 Stable 11/26/10 Mailing List Manager&lt;/a&gt;&lt;/p&gt;

 




&lt;/fieldset&gt;
&lt;/form&gt; 



  
&lt;!-- end subscription_form_widget.tmpl --&gt; 
</description>
		 <pubDate>Sun, 27 Mar 2011 17:02:00 GMT</pubDate>
		 <guid>http://www.napser.org/newsletter/mail.cgi/archive/napservesti/20110327110239/</guid>
		</item>

	
	 
		<item>
		 <title>NAPSer vesti br. 106</title>
		 <link>http://www.napser.org/newsletter/mail.cgi/archive/napservesti/20110308022850/</link>
		 <description>



&#60;p style=&#34;MAX-WIDTH: 640px&#34;&#62;&#60;/p&#62;
&#60;div style=&#34;TEXT-ALIGN: justify&#34;&#62;&#60;/div&#62;
&#60;p style=&#34;MAX-WIDTH: 640px&#34;&#62;
&#60;table style=&#34;WIDTH: 634px; HEIGHT: 795px&#34; border=&#34;0&#34; cellpadding=&#34;1&#34; cellspacing=&#34;0&#34;&#62;
&#60;tbody&#62;
&#60;tr align=&#34;justify&#34;&#62;
&#60;td style=&#34;BACKGROUND-COLOR: rgb(106,165,119); WIDTH: 470px; HEIGHT: 140px&#34; 
    &#62;&#60;span style=&#34;FONT-SIZE: xx-large&#34;&#62;&#60;span style=&#34;FONT-FAMILY: Verdana&#34;&#62;&#60;span style=&#34;COLOR: rgb(255,255,255)&#34; 
      &#62;NAPSer Vesti&#60;/span&#62;&#60;/span&#62;&#60;/span&#62;&#60;/td&#62;
&#60;td style=&#34;WIDTH: 140px; HEIGHT: 140px; COLOR: rgb(96,176,113)&#34; 
    &#62;
      &#60;div style=&#34;TEXT-ALIGN: right&#34;&#62;
      &#60;/div&#62;
&#60;div style=&#34;TEXT-ALIGN: right; WIDTH: 141px; MARGIN-LEFT: 0px&#34;&#62;&#60;STRONG&#62;&#60;FONT 
      face=Verdana&#62;Utorak&#60;/FONT&#62;&#60;/STRONG&#62;&#60;/div&#62;
      &#60;div style=&#34;TEXT-ALIGN: right&#34;&#62;
      &#60;/div&#62;
&#60;p style=&#34;TEXT-ALIGN: right&#34;&#62;&#60;span style=&#34;FONT-SIZE: medium&#34;&#62;&#60;span style=&#34;FONT-FAMILY: Verdana&#34;&#62;&#60;strong&#62;08.&#38;nbsp;Mart &#60;br&#62;2011.&#60;/strong&#62;&#60;/span&#62;&#60;/span&#62;&#60;/p&#62;
&#60;/td&#62;
&#60;td style=&#34;HEIGHT: 140px&#34; width=&#34;10&#34;&#62;&#38;nbsp;&#60;/td&#62;
&#60;/tr&#62;
&#60;tr align=&#34;justify&#34;&#62;
&#60;td style=&#34;WIDTH: 140px; HEIGHT: 284px&#34; colspan=&#34;2&#34;&#62;
&#60;p&#62;&#60;span style=&#34;FONT-SIZE: large&#34;&#62;&#60;span style=&#34;FONT-FAMILY: Verdana&#34;&#62;Dobro dosli u 106. NAPSer
Vesti!&#60;/span&#62;&#60;/span&#62;&#60;/p&#62;
&#60;p&#62;&#60;span style=&#34;FONT-SIZE: small&#34;&#62; Najnovije
vesti, informacije o dogadajima kod nas i u svetu direktno u vašem elektronskom poštanskom sanducetu.&#60;/span&#62;&#60;/p&#62;
&#60;p style=&#34;HEIGHT: 20px; COLOR: rgb(96,176,113)&#34;  &#62;&#60;a href=&#34;http://www.napser.org&#34; target=&#34;_blank&#34;&#62;&#60;strong&#62;&#60;span style=&#34;FONT-SIZE: small&#34;&#62;&#60;span style=&#34;FONT-FAMILY: Verdana&#34;&#62;www.napser.org&#60;/span&#62;&#60;/span&#62;&#60;/strong&#62;&#60;/a&#62;&#60;/p&#62;
&#60;/td&#62;
&#60;td style=&#34;HEIGHT: 284px&#34; width=&#34;10&#34;&#62;&#38;nbsp;&#60;/td&#62;
&#60;/tr&#62;
&#60;tr&#62;
&#60;td colspan=&#34;2&#34; style=&#34;BACKGROUND-COLOR: rgb(93,181,199); WIDTH: 140px&#34;   &#62;
      &#60;div style=&#34;TEXT-ALIGN: justify&#34;&#62;

      &#60;/div&#62;
&#60;div style=&#34;TEXT-ALIGN: justify; BACKGROUND-COLOR: white&#34;&#62;
      &#60;div style=&#34;TEXT-ALIGN: justify&#34;&#62;
      &#60;/div&#62;
&#60;div style=&#34;TEXT-ALIGN: justify&#34;&#62;
      &#60;div style=&#34;TEXT-ALIGN: justify&#34;&#62;
      &#60;/div&#62;&#60;A href=&#34;mailto:&#38;#x70;&#38;#108;&#38;#x65;&#38;#x7A;&#38;#64;&#38;#109;&#38;#x69;&#38;#98;&#38;#46;&#38;#x65;&#38;#x64;&#38;#117;&#34;&#62;&#60;/A&#62;
&#60;/div&#62;
      &#60;span style=&#34;COLOR: #000000&#34;&#62;&#60;DIV style=&#34;TEXT-ALIGN: justify&#34;&#62;&#60;STRONG&#62;&#60;FONT size=4&#62;&#60;center&#62;4. Farmakoterapijski 
      pristup (BPSA)&#60;/center&#62;&#60;/FONT&#62;&#60;/STRONG&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;&#60;br&#62;&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;&#38;nbsp;&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;Farmakoterapijski pristup &#34;Farmakoterapija 
      u starijoj životnoj dobi&#34; ce se&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;održati na Medicinskom fakultetu, 
      Univerziteta u Beogradu, u subotu 12.03. i&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;nedelju, 13.03.2011.&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;&#38;nbsp;&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;PREDAVANJA:&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;&#60;BR&#62;Amfiteatar Instituta za patologiju MF, 
      Dr Subotica starijeg 1, subota 12.03.2011., 13:30 - 16:30.&#60;BR&#62;Broj 
      ucesnika na predavanjima je 200 (100 studenata medicine + 100 studenata 
      farmacije)&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;&#60;BR&#62;13:30 - 13:45 - Uvodna rec&#60;BR&#62;13:45 - 
      14:15 - Osnovni principi primene lekova kod starih (prof. Dragoslav 
      Miloševic, MF)&#60;BR&#62;14:15 - 14:45 - Specificnosti farmakokinetike kod 
      starijih osoba (prof. dr Branislava Miljkovic, dr sc Katarina Vucicevic, 
      FF)&#60;BR&#62;14:45 - 15:15 - Farmaceutska zdravstvena zaštita kod starijih osoba 
      (doc. dr Sandra Vezmar, FF)&#60;BR&#62;15:15 - 15:45 - Neželjena dejstva lekova 
      kod starijih osoba (prof. Zoran Todorovic, MF)&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;15:45 - 16:15 - Bioeticki aspekti 
      farmakoterapije u starijoj životnoj dobi (dr Nevena Milosavljevic)&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;&#60;BR&#62;RADIONICE:&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;&#38;nbsp;&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;Na radionici ce studenti uz pomoc 
      moderatora obradivati slucajeve pacijenata sa problemima karakteristicnim 
      za stariju dob. Studenti ce biti podeljeni u cetiri tima, a svaki tim se 
      sastoji od po tri studenta farmacije i tri studenta medicine. U rešavanju 
      slucaja, svaki tim ce imati podršku dva moderatora. Za radionice se ukupno 
      moze prijaviti 12 studenata farmacije i 12 studenata medicine. Radionica 
      ce se održati u vežbaonici Instituta za farmakologiju, klinicku 
      farmakologiju i toksikologiju MF, Dr Subotica starijeg 1/III, u nedelju 
      13.03.2011., 10:00 - 13:00.&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;&#60;BR&#62;MODERATORI:&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;&#60;BR&#62;MF - doc. Nebojša Despotovic, dr 
      Katarina Savic Vujovic, dr Branislava Medic, asist. dr Maja Lozic&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;FF - dr Katarina Vucicevic, mr sc Milica 
      Culafic, dipl. farm. Marija Jovanovic, dipl. farm. Milica Jankovic &#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;&#60;BR&#62;Za radionice se studenti farmacije 
      mogu prijaviti&#38;nbsp;&#60;A 
      href=&#34;https://spreadsheets.google.com/viewform?formkey=dDhaUXV4YzRiblNyeGRYQkZXZjFoMVE6MQ&#34; 
      target=_blank&#62;ovde&#60;/A&#62;.&#60;BR&#62;Prednost pri prijavljivanju ce imati studenti koji 
      su polozili i farmakologiju i farmakokinetiku. Rok za slanje prijava 
      je 10.03.2011. do 12 casova.&#60;/DIV&#62;
      &#60;DIV style=&#34;TEXT-ALIGN: left&#34;&#62;
      &#60;br&#62;&#60;/DIV&#62;&#60;/DIV&#62;&#60;/span&#62;
&#60;/div&#62;
&#60;/td&#62;
&#60;td&#62;&#60;br&#62;
&#60;/td&#62;
&#60;/tr&#62;
&#60;/tbody&#62;
&#60;/table&#62;
&#60;/p&#62;



&lt;!-- begin subscription_form_widget.tmpl --&gt; 



 

    &lt;form action=&quot;http://www.napser.org/newsletter/mail.cgi&quot; method=&quot;post&quot;&gt;

 

&lt;fieldset&gt;
&lt;legend&gt;
 Subscribe/Unsubscribe  on NAPSer vesti
&lt;/legend&gt;

 
    

    &lt;input type=&quot;hidden&quot; name=&quot;list&quot; value=&quot;napservesti&quot; /&gt;


&lt;p&gt;
&lt;label for=&quot;email&quot; style=&quot;width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block&quot; &gt;
Email&amp;nbsp;Address: 
&lt;/label&gt;
 
	&lt;input type=&quot;text&quot; name=&quot;email&quot; id=&quot;email&quot; value=&quot;&quot; /&gt; &lt;span class=&quot;error&quot;&gt;* Required&lt;/span&gt;
 

&lt;/p&gt;

 

	 

 


&lt;hr style=&quot;border-top: 1px solid black;&quot; /&gt; 

 
    &lt;p&gt;
    &lt;label for=&quot;f_s&quot; style=&quot;width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block&quot;&gt;
    Subscribe
    &lt;/label&gt;
    &lt;input type=&quot;radio&quot; name=&quot;f&quot; id=&quot;f_s&quot; value=&quot;subscribe&quot; checked=&quot;checked&quot; /&gt;
    &lt;/p&gt; 
    
    &lt;p&gt; 
    &lt;label for=&quot;f_u&quot; style=&quot;width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block&quot;&gt;Unsubscribe&lt;/label&gt; 
    &lt;input type=&quot;radio&quot; name=&quot;f&quot;  id=&quot;f_u&quot;  value=&quot;unsubscribe&quot;  /&gt;
    &lt;/p&gt;   

 

&lt;hr style=&quot;border-top: 1px solid black;&quot; /&gt; 

&lt;p style=&quot;text-align:right;display:block&quot;&gt;
&lt;input type=&quot;submit&quot; value=&quot;Submit Your Information&quot; class=&quot;processing&quot; /&gt;
&lt;/p&gt; 


 

    &lt;p style=&quot;font-size:10px;font-family:Verdana,Arial,sans-serif;&quot;&gt;&lt;a href=&quot;http://dadamailproject.com&quot; target=&quot;_blank&quot; style=&quot;font-size:10px;font-family:Verdana,Arial,sans-serif;&quot;&gt;Powered by Dada Mail 4.3.0 Stable 11/26/10 Mailing List Manager&lt;/a&gt;&lt;/p&gt;

 




&lt;/fieldset&gt;
&lt;/form&gt; 



  
&lt;!-- end subscription_form_widget.tmpl --&gt; 
</description>
		 <pubDate>Tue, 08 Mar 2011 09:28:00 GMT</pubDate>
		 <guid>http://www.napser.org/newsletter/mail.cgi/archive/napservesti/20110308022850/</guid>
		</item>

	
	 
		<item>
		 <title>NAPSer vesti br. 105</title>
		 <link>http://www.napser.org/newsletter/mail.cgi/archive/napservesti/20101214152602/</link>
		 <description>



&#60;p style=&#34;max-width: 640px;&#34;&#62;&#60;/p&#62;
&#60;div style=&#34;text-align: justify;&#34;&#62;&#60;/div&#62;
&#60;p style=&#34;max-width: 640px;&#34;&#62;
&#60;table style=&#34;width: 634px; height: 795px;&#34; border=&#34;0&#34; cellpadding=&#34;1&#34;
cellspacing=&#34;0&#34;&#62;
&#60;tbody&#62;
&#60;tr align=&#34;justify&#34;&#62;
&#60;td
style=&#34;background-color: rgb(106, 165, 119); width: 470px; height: 140px;&#34;&#62;&#60;span
style=&#34;font-size: xx-large;&#34;&#62;&#60;span style=&#34;font-family: Verdana;&#34;&#62;&#60;span
style=&#34;color: rgb(255, 255, 255);&#34;&#62;NAPSer Vesti&#60;/span&#62;&#60;/span&#62;&#60;/span&#62;&#60;/td&#62;
&#60;td style=&#34;color: rgb(96, 176, 113); width: 140px; height: 140px;&#34;&#62;
&#60;div style=&#34;text-align: right;&#34;&#62; &#60;/div&#62;
&#60;div style=&#34;margin-left: 0px; width: 141px; text-align: right;&#34;&#62;&#60;span
style=&#34;font-family: Verdana;&#34;&#62;&#60;span style=&#34;font-weight: bold;&#34;&#62;Utorak&#60;/span&#62;&#60;/span&#62;&#60;/div&#62;
&#60;div style=&#34;text-align: right;&#34;&#62; &#60;/div&#62;
&#60;p style=&#34;text-align: right;&#34;&#62;&#60;span style=&#34;font-size: medium;&#34;&#62;&#60;span
style=&#34;font-family: Verdana;&#34;&#62;&#60;strong&#62;14. decembar &#60;br&#62;
2010.&#60;/strong&#62;&#60;/span&#62;&#60;/span&#62;&#60;/p&#62;
&#60;/td&#62;
&#60;td style=&#34;height: 140px;&#34; width=&#34;10&#34;&#62;&#38;nbsp;&#60;/td&#62;
&#60;/tr&#62;
&#60;tr align=&#34;justify&#34;&#62;
&#60;td style=&#34;width: 140px; height: 284px;&#34; colspan=&#34;2&#34;&#62;
&#60;p&#62;&#60;span style=&#34;font-size: large;&#34;&#62;&#60;span
style=&#34;font-family: Verdana;&#34;&#62;Dobro došli u 105. NAPSer
Vesti!&#60;/span&#62;&#60;/span&#62;&#60;/p&#62;
&#60;p&#62;&#60;span style=&#34;font-size: small;&#34;&#62;Najnovije
vesti, informacije o događajima kod nas i u svetu direktno u vašem
elektronskom poštanskom sandučetu.&#60;/span&#62;&#60;/p&#62;
&#60;p style=&#34;color: rgb(96, 176, 113); height: 20px;&#34;&#62;&#60;a
href=&#34;http://www.napser.org&#34; target=&#34;_blank&#34;&#62;&#60;strong&#62;&#60;span
style=&#34;font-size: small;&#34;&#62;&#60;span style=&#34;font-family: Verdana;&#34;&#62;www.napser.org&#60;/span&#62;&#60;/span&#62;&#60;/strong&#62;&#60;/a&#62;&#60;/p&#62;
&#60;/td&#62;
&#60;td style=&#34;height: 284px;&#34; width=&#34;10&#34;&#62;&#38;nbsp;&#60;/td&#62;
&#60;/tr&#62;
&#60;tr&#62;
&#60;td colspan=&#34;2&#34; rowspan=&#34;1&#34;
style=&#34;background-color: rgb(93, 181, 199); width: 140px;&#34;&#62;
&#60;div style=&#34;text-align: justify;&#34;&#62; &#60;/div&#62;
&#60;div style=&#34;text-align: justify; background-color: white;&#34;&#62;
&#60;div style=&#34;text-align: justify;&#34;&#62; &#60;/div&#62;
&#60;div style=&#34;text-align: justify;&#34;&#62;
&#60;div style=&#34;text-align: justify;&#34;&#62; &#60;/div&#62;
&#60;div style=&#34;text-align: center;&#34;&#62;
&#60;div style=&#34;text-align: justify;&#34;&#62;
&#60;div style=&#34;text-align: center;&#34;&#62;&#60;span style=&#34;font-weight: bold;&#34;&#62;Osmeh
na dar&#60;/span&#62;&#60;br&#62;
&#60;/div&#62;
&#60;br&#62;
&#38;nbsp;&#38;nbsp;&#38;nbsp; Želimo da vas obavestimo da ćemo treću godinu za
redom organizovati akciju &#34;Osmeh na dar&#34;. U pitanju je humanitarna
akcija prikupljanja novogodišnjih paketića za decu iz najugroženijih
enklava sa područja Kosova i Metohije. Prethodne dve godine izmamili
smo preko dvesta osmeha. Nadamo se da ćete i ove godine pokazati koliko
humani farmaceuti mogu da budu!&#60;br&#62;
&#38;nbsp;&#38;nbsp;&#38;nbsp; Dežuraćemo u holu Fakulteta u periodu od 11 do 14h
od 10. decembra (petak) do 21.decembra (utorak). Prikupljaju se
slatkiši, igračke, školski pribor i novac. Zamolili bi sve da stvari
ipak budu nove ili jako lepo očuvane.&#60;br&#62;
&#60;br&#62;
Vidimo se !&#60;br&#62;
&#60;br&#62;
Public Health tim NAPSer-a u saradnji sa članovima Fonda Osmeh na dar&#60;br&#62;
&#60;/div&#62;
&#60;br&#62;
&#60;br&#62;
&#60;span style=&#34;font-weight: bold;&#34;&#62;Novi PSANS tim za 2010&#60;br&#62;
&#60;br&#62;
&#60;/span&#62;
&#60;div style=&#34;text-align: justify;&#34;&#62;Na osnovu pristiglih prijava i
posle održanog 1. i 2. kruga izbora u PSANS-u, obaveštavamo Vas da je
izabran novi PSANS tim za 2011. godinu.&#60;br&#62;
&#60;br&#62;
Predsednik: Tatjana Pavić&#60;br&#62;
Sekretar: Nataša Savčić&#60;br&#62;
Blagajnik: Branislava Rakić&#60;br&#62;
&#60;br&#62;
PCE koordinator: Dana Dragosavac&#60;br&#62;
CSE koordinator: Jelena Gajić&#60;br&#62;
LEO: Gordana Arsenov&#60;br&#62;
Koordinator akcija Javnog zdravlja: Kristina Bjelica&#60;br&#62;
LMO koordinator: Ana Šarčević&#60;br&#62;
EFK koordinator: Marko Milović&#60;br&#62;
IMP koordinator: Aljoša Stanković&#60;br&#62;
Dizajner: Srđan Radak&#60;br&#62;
&#60;br&#62;
Nadzorni odbor: Nina Bukumirović, Ljubica Vaščić i Marina Gavrančić.&#60;br&#62;
&#60;br&#62;
Čestitamo novoizabranim kandidatima i želimo celom timu uspešan rad u
2011. godini.&#60;span style=&#34;font-weight: bold;&#34;&#62;&#60;/span&#62;&#60;br&#62;
&#60;span style=&#34;font-weight: bold;&#34;&#62;&#60;/span&#62;&#60;/div&#62;
&#60;/div&#62;
&#60;/div&#62;
&#60;/div&#62;
&#60;/td&#62;
&#60;td&#62;&#60;br&#62;
&#60;/td&#62;
&#60;/tr&#62;
&#60;/tbody&#62;
&#60;/table&#62;
&#60;/p&#62;



&lt;!-- begin subscription_form_widget.tmpl --&gt; 



 

    &lt;form action=&quot;http://www.napser.org/newsletter/mail.cgi&quot; method=&quot;post&quot;&gt;

 

&lt;fieldset&gt;
&lt;legend&gt;
 Subscribe/Unsubscribe  on NAPSer vesti
&lt;/legend&gt;

 
    

    &lt;input type=&quot;hidden&quot; name=&quot;list&quot; value=&quot;napservesti&quot; /&gt;


&lt;p&gt;
&lt;label for=&quot;email&quot; style=&quot;width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block&quot; &gt;
Email&amp;nbsp;Address: 
&lt;/label&gt;
 
	&lt;input type=&quot;text&quot; name=&quot;email&quot; id=&quot;email&quot; value=&quot;&quot; /&gt; &lt;span class=&quot;error&quot;&gt;* Required&lt;/span&gt;
 

&lt;/p&gt;

 

	 

 


&lt;hr style=&quot;border-top: 1px solid black;&quot; /&gt; 

 
    &lt;p&gt;
    &lt;label for=&quot;f_s&quot; style=&quot;width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block&quot;&gt;
    Subscribe
    &lt;/label&gt;
    &lt;input type=&quot;radio&quot; name=&quot;f&quot; id=&quot;f_s&quot; value=&quot;subscribe&quot; checked=&quot;checked&quot; /&gt;
    &lt;/p&gt; 
    
    &lt;p&gt; 
    &lt;label for=&quot;f_u&quot; style=&quot;width: 7em;float: left;text-align: right;margin-right: 0.5em;display: block&quot;&gt;Unsubscribe&lt;/label&gt; 
    &lt;input type=&quot;radio&quot; name=&quot;f&quot;  id=&quot;f_u&quot;  value=&quot;unsubscribe&quot;  /&gt;
    &lt;/p&gt;   

 

&lt;hr style=&quot;border-top: 1px solid black;&quot; /&gt; 

&lt;p style=&quot;text-align:right;display:block&quot;&gt;
&lt;input type=&quot;submit&quot; value=&quot;Submit Your Information&quot; class=&quot;processing&quot; /&gt;
&lt;/p&gt; 


 

    &lt;p style=&quot;font-size:10px;font-family:Verdana,Arial,sans-serif;&quot;&gt;&lt;a href=&quot;http://dadamailproject.com&quot; target=&quot;_blank&quot; style=&quot;font-size:10px;font-family:Verdana,Arial,sans-serif;&quot;&gt;Powered by Dada Mail 4.3.0 Stable 11/26/10 Mailing List Manager&lt;/a&gt;&lt;/p&gt;

 




&lt;/fieldset&gt;
&lt;/form&gt; 



  
&lt;!-- end subscription_form_widget.tmpl --&gt; 
</description>
		 <pubDate>Tue, 14 Dec 2010 22:26:00 GMT</pubDate>
		 <guid>http://www.napser.org/newsletter/mail.cgi/archive/napservesti/20101214152602/</guid>
		</item>

	

 </channel>
</rss>


